The startup created a virtual companion as a mobile application that improves the daily lives of patients with chronic diseases or cancer. Success has encouraged Wefight to expand its solution’s features and go international.
Much more than a conversation interfaceThat’s the whole point of Vik. Designed to help people break out of their solitude with respect to their illness, the Vik personal companion is much more than just a conversation interface. While the solution leverages databases and artificial intelligence algorithms, it also goes much further, configured to understand patients’ specific questions concerning different types of chronic diseases. In each case, the company’s work involves experts, doctors, patient associations, and more. Their joint effort enriches databases filled with reliable document resources and helps increase the relevance of answers provided to patients’ questions.
Over 30 diseases targetedAvailable on iOS, Android, Facebook Messenger, and the Wefight website, Vik is currently available for patients with breast cancer, lung cancer, ovary cancer, asthma, migraines, and depression. A new version of Vik dedicated to atopic dermatitis was added in late October.
The company’s next step is to launch Vik with support for prostate cancer.
“Our goal is to expand our companion’s features to cover over 30 chronic diseases,” announces Benoît Brouard.
More fund raising on the horizonAssisted by Montpellier BIC, the startup has undergone exponential growth since it was founded in 2017. Winner of the Next French Healthcare competition in June 2020, organized by Business France and Bpifrance, Wefight now has nearly 200,000 users in France. The company is now launching its activities abroad. Vik Asthma is available in Germany, Canada, Spain, and Italy. Wefight continues to hire in order to keep up with its expansion.
“We expect our staff to comprise 30 people by the end of 2020,” adds Benoît Brouard, who pays careful attention to team unity and corporate culture. “Our ethics and social purpose are shared by everyone in the company,” he highlights.